Recently Published Articles

Volume 1, Issue 1

Am J Blood Rev. 2021;1(1):1001. | Review Article | Open Access
Abstract | Fulltext PDF

SARS-CoV-2 and Proteolytic Storm: Neutrophils and Proteolytic Enzymes are the “Prima Donna” in Severe COVID-19. Serine Proteases Inhibitors are Valuable Treatment Options

Pier Maria Fornasari

Share This Article:

---